People genetically prone to Alzheimer's showed less cognitive decline when they ate more meat

JAMA Network Open / Karolinska Institutet

The APOE epsilon-4 allele is the strongest common genetic risk factor for Alzheimer's disease. Carry one copy and your risk triples. Carry two and it can rise tenfold. About 30% of Swedes carry at least one copy. Among those who develop Alzheimer's, the proportion is nearly 70%.

So when a 15-year study of more than 2,100 older Swedish adults found that high meat consumption appeared to neutralize the cognitive disadvantage associated with these gene variants, it caught attention — not because the finding was expected, but because it cuts against decades of dietary guidance that has treated meat, particularly red meat, as broadly detrimental to brain health.

The study, published March 19 in JAMA Network Open, comes from Karolinska Institutet and draws on the Swedish National Study on Aging and Care, Kungsholmen (SNAC-K).

An evolutionary hypothesis tested in a modern cohort

The study was not a fishing expedition. It tested a specific hypothesis: that the APOE4 variant — the evolutionarily oldest form of the gene — may have arisen when human ancestors ate a more animal-based diet. If that is true, carriers of this variant might metabolize and benefit from dietary components in meat differently than people with newer APOE variants.

All participants were aged 60 or older with no dementia diagnosis at enrollment. Researchers tracked self-reported dietary intake and administered cognitive assessments over the follow-up period, adjusting for age, sex, education, and lifestyle factors.

The results split cleanly along genetic lines. Among people with APOE 3/4 or 4/4 genotypes, those with lower meat intake had more than twice the dementia risk compared to people without these gene variants. But in the highest fifth of meat consumers — eating a median of roughly 870 grams per week, standardized to 2,000 daily calories — the expected cognitive disadvantage simply was not there.

"Those who ate more meat overall had significantly slower cognitive decline and a lower risk of dementia, but only if they had the APOE 3/4 or 4/4 gene variants," said first author Jakob Norgren, PhD, a researcher at Karolinska Institutet's Department of Neurobiology, Care Sciences and Society.

Processed versus unprocessed: a critical distinction

The type of meat mattered. A lower proportion of processed meat in total meat consumption was associated with reduced dementia risk regardless of APOE genotype. This held across the entire cohort, not just among genetic risk carriers.

In a secondary analysis, the researchers also found that APOE 3/4 and 4/4 carriers who consumed more unprocessed meat had significantly lower all-cause mortality. The benefits, in other words, extended beyond brain health.

"A lower proportion of processed meat in total meat consumption was associated with a lower risk of dementia regardless of APOE genotype," said Sara Garcia-Ptacek, assistant professor at Karolinska Institutet and a senior author of the study.

What this means for dietary recommendations

Current dietary guidelines in many countries recommend limiting red meat consumption for cardiovascular and cancer risk reduction. These guidelines do not typically differentiate by genotype. The SNAC-K results suggest that for a substantial genetic subgroup — roughly one in three Swedes, and a meaningful fraction of other populations — this advice may not serve brain health.

Norgren was direct about the implications: "There is a lack of dietary research into brain health, and our findings suggest that conventional dietary advice may be unfavourable to a genetically defined subgroup of the population. For those who are aware that they belong to this genetic risk group, the findings offer hope; the risk may be modifiable through lifestyle changes."

He also noted that APOE4 prevalence is roughly twice as high in Nordic countries as in Mediterranean ones, which has implications for how universally Mediterranean-style dietary advice should be applied.

The limits of an observational design

This is an observational study. It cannot establish that eating meat caused the cognitive protection. People who eat more meat may differ from those who eat less in ways the researchers could not fully measure — income, overall caloric adequacy, social engagement, access to healthcare. Self-reported dietary data is notoriously imprecise, and food frequency questionnaires capture habits at a snapshot, not lifelong patterns.

The cohort was also exclusively Swedish, elderly, and drawn from a single urban area (Kungsholmen, Stockholm). Whether the same interaction between APOE genotype and meat consumption holds in other ethnic groups, younger populations, or different dietary contexts is unknown.

And there is the question of mechanism. The study does not explain why meat might protect APOE4 carriers. Possible explanations include differences in cholesterol metabolism, iron bioavailability, vitamin B12, or amino acid profiles — but these are speculative. Without a clear biological pathway, the association remains intriguing rather than actionable.

"Clinical trials are now needed to develop dietary recommendations tailored to APOE genotype," Norgren said. Until those trials are completed, the findings inform discussion but do not rewrite the menu.